Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel 3-step cabazitaxel synthesis from 7,10-dimethoxy-10-deacetylbaccatin III. High purity, mild conditions, scalable for pharmaceutical intermediates supply.
Patent CN103396344B reveals a one-pot CDI method for Boceprevir intermediates, offering high purity, reduced toxicity, and scalable manufacturing for global supply chains.
Advanced synthesis of Raloxifene intermediate via improved ethanol-based process. High purity, cost-effective manufacturing solution for pharmaceutical supply chains.
Patent CN103087013B details efficient paclitaxel production from 10DAXT offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel micro-channel hydrogenation route for Avibactam Sodium. High purity >99.9%, safe scale-up, reduced toxicity. Ideal for API manufacturing.
Patent CN101244994B details a safe, high-yield route for 2,4,5-trifluorophenylacetic acid via Willgerodt-Kindler reaction, offering significant cost and safety advantages for Sitagliptin production.
Advanced synthesis of Dibenzo[b,f]azepine derivatives for Oxcarbazepine production. Novel carbamylation process ensures high purity and cost-effective API manufacturing.
Patent CN104745550B enables high-purity statin intermediate production with mild conditions, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Discover the novel industrial synthesis of 2-aminomethyl-4-cyano-thiazole via patent CN1364164A. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN101531682A details a green hydrothermal method for synthesizing defined Pd and Pt coordination complexes, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN114805155A reveals a novel method for L-selenomethylselenocysteine using elemental selenium. Offers safer, scalable production for nutritional supplement manufacturers.
Patent CN119698468A details engineered transaminases for niraparib synthesis, offering high stereoselectivity and scalable biocatalytic solutions for pharmaceutical supply chains.
Patent CN109251207B discloses a novel method for synthesizing chiral lactones with high yield and recyclable auxiliaries, offering significant cost reduction in API manufacturing.
Patent CN119798059A reveals a high-yield route for Mirogabalin intermediates, offering significant supply chain stability and cost reduction potential.
Discover a safer, high-yield synthesis route for 3-(piperidin-4-yl)oxazolidin-2-one via patent CN110483490B, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel acetylation process eliminates pyridine, achieving greater than 99.7 percent purity. Cost-effective and scalable solution for pharmaceutical intermediates manufacturing.
Patent CN113603721A details a scalable chemical synthesis of SAICAR from Inosine, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing compared to biosynthesis.
Novel electrochemical NHK reaction reduces waste and time for Eribulin intermediate ERB manufacturing, offering cost-effective supply chain solutions.
Patent CN102557947A reveals a high-yield, one-step synthesis for 5-bromoacetylsalicylic acid methyl ester, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel copper-catalyzed defluorinative thiolation method offers high yields and mild conditions for producing alpha-fluorinated thioacrylamide derivatives efficiently.